This article shows that Medical Innovation—the landmark study by Coleman, Katz, and Menzel—and several subsequent studies analyzing the diffusion of the drug tetracycline have confounded social contagion with marketing effects. The article describes the medical community’s understanding of tetracycline and how the drug was marketed. This situational analysis finds no reasons to expect social contagion; instead, aggressive marketing efforts may have played an important role. The Medical Innovation data set is reanalyzed and supplemented with newly collected advertising data. When marketing efforts are controlled for, contagion effects disappear. The article underscores the importance of controlling for potential confounds when studying the r...
We use a social contagion lens to study the dynamic, temporal process of the diffusion of electronic...
The article aims at identifying micro- and mesolevel characteristics of the early prescribers of new...
Medical doctors occasionally discover potentially valuable new off-label uses for drugs during their...
This article shows that Medical Innovation—the landmark study by Coleman, Katz, and Menzel—and sever...
This article shows that Medical Innovation—the landmark study by Coleman, Katz, and Menzel—and sever...
This paper shows that Medical Innovation (Coleman, Katz and Menzel 1966) and several subsequent stud...
This article presents a multilevel event history model of social diffusion and applies it to Coleman...
In this paper, we reanalyze Medical Innovation, the classic study on diffusion of Tetracycline by Co...
In this paper, we reanalyze Medical Innovation, the classic study on diffusion of a new drug Tetracy...
Advances in viral marketing and social media have made buzz the hot topic of 2010. This paper report...
Advances in viral marketing and social media have made buzz the hot topic of 2010. This paper report...
This article studies the determinants of pharmaceutical innovation diffusion among specialists. To ...
This article aims to provide a reassessment of the processes of diffusion of innovations into organi...
Thesis (Ph.D.)--Massachusetts Institute of Technology, Sloan School of Management, 2001.Includes bib...
In this paper, we reanalyze Medical Innovation, the classic study on diffusion of Tetracycline by Co...
We use a social contagion lens to study the dynamic, temporal process of the diffusion of electronic...
The article aims at identifying micro- and mesolevel characteristics of the early prescribers of new...
Medical doctors occasionally discover potentially valuable new off-label uses for drugs during their...
This article shows that Medical Innovation—the landmark study by Coleman, Katz, and Menzel—and sever...
This article shows that Medical Innovation—the landmark study by Coleman, Katz, and Menzel—and sever...
This paper shows that Medical Innovation (Coleman, Katz and Menzel 1966) and several subsequent stud...
This article presents a multilevel event history model of social diffusion and applies it to Coleman...
In this paper, we reanalyze Medical Innovation, the classic study on diffusion of Tetracycline by Co...
In this paper, we reanalyze Medical Innovation, the classic study on diffusion of a new drug Tetracy...
Advances in viral marketing and social media have made buzz the hot topic of 2010. This paper report...
Advances in viral marketing and social media have made buzz the hot topic of 2010. This paper report...
This article studies the determinants of pharmaceutical innovation diffusion among specialists. To ...
This article aims to provide a reassessment of the processes of diffusion of innovations into organi...
Thesis (Ph.D.)--Massachusetts Institute of Technology, Sloan School of Management, 2001.Includes bib...
In this paper, we reanalyze Medical Innovation, the classic study on diffusion of Tetracycline by Co...
We use a social contagion lens to study the dynamic, temporal process of the diffusion of electronic...
The article aims at identifying micro- and mesolevel characteristics of the early prescribers of new...
Medical doctors occasionally discover potentially valuable new off-label uses for drugs during their...